The global genotyping assay market is projected to reach USD 31.9 billion by 2023 from USD 11.8 billion in 2018, at a CAGR of 22.0%. The growth of this market is mainly driven by technological ad ...
The global synthetic biology market in terms of revenue was estimated to be worth $11.4 billion in 2022 and is poised to reach $35.7 billion by 2027, growing at a CAGR of 25.6% from 2022 to 2027. ...
The global human microbiome market in terms of revenue was estimated to be worth $0.3 billion in 2023 and is poised to reach $1.7 billion by 2029, growing at a CAGR of 36.1% from 2023 to 2029.
This global whole exome sequencing market was valued at $326.6 million in 2013 and is expected to grow at a CAGR of 22.0% from 2013 to 2018, to reach $884.1 million by 2018. The market is dominat ...
The global breast cancer liquid biopsy market is projected to grow at a CAGR of 23.1%. Factors such as increasing prevalence of breast cancer, increasing preference for noninvasive procedures, in ...
The global AI in genomics market in terms of revenue was estimated to be worth $0.5 billion in 2023 and is poised to reach $2.0 billion by 2028, growing at a CAGR of 32.3% from 2023 to 2028. The ...
The global next generation sequencing market in terms of revenue was estimated to be worth $13 billion in 2022 and is poised to reach $27 billion by 2027, growing at a CAGR of 15.7% from 2022 to ...
The global cell analysis market in terms of revenue was estimated to be worth $20.2 billion in 2023 and is poised to reach $33.9 billion by 2028, growing at a CAGR of 10.9% from 2023 to 2028. The ...
The global proteomics market in terms of revenue was estimated to be worth $36.8 billion in 2023 and is poised to reach $72.9 billion by 2028, growing at a CAGR of 14.6% from 2023 to 2028. The ne ...
The global genomics market in terms of revenue was estimated to be worth $46.2 billion in 2023 and is poised to reach $83.1 billion by 2028, growing at a CAGR of 12.4% from 2023 to 2028. The new ...
The global esoteric testing market is projected to reach USD 36.3 billion by 2026, at a CAGR of 11.6% during the forecast period. The global esoteric testing market is consolidated. The prominent ...
The global biomarker technologies market is projected to grow at a CAGR of 9.7%. The key players in the biomarker technologies market are Thermo Fisher Scientific (US), Agilent Technologies (US), ...
Latent demand for you, for your prospective client, or your prospective partners